SynthesisDiabetic medicine : a journal of the British Diabetic Association2017

Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 receptor agonist, in African-American people with Type 2 diabetes: a meta-analysis of sub-population data from seven phase III trials.

M E Shomali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.